MedTrace Logo

Postoperative Analgesia After Laparoscopic Living Donor Nephrectomy

NCT01059331 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2014-03-21

No results posted yet for this study

Summary

The aim of the study is to investigate if perioperative administration of pregabalin vil reduce postoperative pain and the postoperative need for intravenous opioids compared with todays standard treatment which consist of paracetamol, corticoids and ketobemidone.

In addition potential sideeffects as sedation and effect on cognitive function will be recorded.

Conditions

  • Living Donors

Interventions

DRUG

Pregabalin

150 mg x 2 daily for 2 days

DRUG

Sugar pill

1 tablet x 2 daily, for 2 days

Sponsors & Collaborators

  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Audun Stubhaug, dr.med. · Universitetet i Oslo, Rikshospitaelt, Anestesi- og intensivavdelingen

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-02-28
Primary Completion
2011-10-31
Completion
2012-12-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01059331 on ClinicalTrials.gov